Novavax

Novavax, Inc., based in Gaithersburg, Maryland, develops vaccines to counter infectious diseases. The company's first and only commercial product is the Novavax COVID-19 vaccine. The company is also developing... Wikipedia

• Type:  Public
• Traded as:  NASDAQ: NVAX
• ISIN:  [ ISIN: [ US6700024010]]
• Industry:  Biotechnology
• Founded:  1987
• Area served:  Worldwide
• Key people:  John C. Jacobs (CEO) James P. Kelly (CFO)
• Products:  Vaccines
• Revenue:  US$682 million (2024)
• Operating income:  - US$248 million (2024)
• Total assets:  US$1.560 billion (2024)
• Total equity:  - US$623 million (2024)
• Number of employees:  952 (2025)
• Data source:  DuckDuckGo